Cancer is among the leading causes of death worldwide, with the number of new cancer
cases expected to rise to 22 million in the next two decades. Most chemotherapy drugs in …

Nanoparticle-based drug delivery systems have emerged as a groundbreaking innovation in
the field of medicine, offering significant advancements over traditional drug delivery …

Nanoparticles are being rapidly developed to overcome several limitations of traditional
drug delivery systems and are coming up as a distinct therapeutics for cancer treatment …

Cancer has become the leading cause of death among different populations of the world.
The treatment is limited to chemotherapy, radiation, and surgery. Selective targeting to the …

This review evaluates the literature on nanoparticle-based drug delivery systems for cancer
treatment and assesses their efficacy. Nanoparticles have shown potential for improving …

Nanomedicine, the application of nanotechnology to medicine, enabled the development of
nanoparticle therapeutic carriers. These drug carriers are passively targeted to tumors …

Background: Targeted cancer therapy aims to maximize therapeutic efficacy while
minimizing adverse effects, a challenge often limited by non-specific drug distribution …

Nanoparticles have been explored as a promising drug carrier for chemotherapy, with
several systems in various stages of commercial development. This chapter describes …

Impact of nanotechnology for anticancer therapy has been projected with great promises for
the past two decades and has been followed with thousands of research publications and …

Nanoparticles are 1–100 nanometers in size. These particles can be used in a targeted drug
delivery approach, as they can specifically target a drug or drug carrier to minimize drug …